DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ferolla P, Brizzi MP, Meyer T. et al.
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol 2017;
18 (12) 1652-1664
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.